Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Bernard ChevallierC Fizames

Abstract

To compare the efficacy and safety of recombinant human granulocyte colony-stimulating factor (rHuG-CSF) versus its inert vehicle in patients with unilateral nonmetastatic inflammatory breast cancer treated with fluorouracil, epirubicin, and cyclophosphamide high-dose (FEC-HD) neoadjuvant chemotherapy. One hundred twenty patients have been enrolled by nine French centers in this double-blind, parallel-group, vehicle-controlled study to compare at each cycle subcutaneous lenograstim (5 micrograms/kg/d) with placebo given from day 6 to day 15 after the induction chemotherapy (day 1 to day 4, fluorouracil 750 mg/m2 continuous intravenous [IV] infusion; day 2 to day 4, epirubicin 35 mg/m2 and cyclophosphamide 400 mg/m2 both IV push). Four cycles were planned every 3 weeks before locoregional treatment. Patients with febrile neutropenia remained blinded for the subsequent cycles. Lenograstim significantly reduced the duration of neutropenia at less than 0.5 x 10(9)/L and less than 1 x 10(9)/L to a median duration of 2 and 3 days, respectively, as compared with 5 and 7 days in the placebo group. This translated into a statistically significant reduced incidence of microbiologically documented infections, and a decreased need for reho...Continue Reading

Citations

Jan 12, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C PatteJ Michon
May 29, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicole M Kuderer, Antonio C Wolff
Jul 22, 2020·Pathology Oncology Research : POR·Anita SejbenTamás Zombori
Jul 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicole M KudererGary H Lyman
Nov 10, 2010·BMC Research Notes·Halima AbahssainHassan Errihani
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·T TajimaM Kubota
Oct 10, 2008·The Cochrane Database of Systematic Reviews·Julia BohliusAndreas Engert
May 1, 2012·PharmacoEconomics·Bradford R Hirsch, Gary H Lyman
Jan 5, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P ViensD Maraninchi
Sep 3, 2009·Journal of Medical Economics·Dawn HershmanJennifer L Malin
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanJeffrey Crawford
Mar 31, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Li WangRichard Barron
Dec 4, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Gary H LymanLodovico Balducci
Apr 20, 2001·Paediatric Drugs·L M Wagner, W L Furman
Sep 18, 2016·Journal of the American Medical Informatics Association : JAMIA·Pamala A PawloskiGary H Lyman
Sep 4, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ahuva AverinDerek Weycker
Dec 5, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F BertucciS J Van Laere
Jun 6, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M S AaproUNKNOWN European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines
Nov 26, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M S AaproUNKNOWN European Organisation for Research and Treatment of Cancer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

© 2021 Meta ULC. All rights reserved